Qilu Evening News Qilu One Point reporter Ma Xueting correspondent Fan Qingyong Sun Guodong
On March 19, with the strong support of the leaders of Heze Municipal Hospital, the team of Interventional Director Fan Qingyong successfully treated 4 patients with essential hypertension The patient underwent percutaneous renal artery sympathetic nerve ablation (RDN), which brought a new treatment option for patients with hypertension who did not meet the standard of primary drug treatment. The main technical team, Fan Qingyong, Zhang Hua, Shang Jiannan, Hao Junshan, Ma Ning, nurses Kang Pei, Zhang Xing, Wang Yanli, Liu Hui, and technician Yin Yingjie participated in the operation together, and Sun Guodong, the agency office, followed the quality control on site.
Hypertension is the most common cardiovascular disease and a major public health problem worldwide. In recent years, although a lot of efforts have been made in the blood pressure compliance rate, the blood pressure compliance rate in my country is only 16.8%. For a long time, the treatment of hypertension was mainly guided by drug therapy and lifestyle intervention. However, many patients faced poor drug treatment results, poor compliance with long-term drug treatment, serious drug side effects, contraindications to drug use, lifelong medication requirements, and heavy economic burden. Therefore, there is an urgent need for a new treatment method other than drug therapy that can control blood pressure stably for a long time.
In 2018, the Interventional Department of Heze Municipal Hospital was the first batch of clinical trial bases for interventional medical devices in China. To meet the treatment needs of patients, while a lot of clinical work, we continue to explore and find innovative treatment solutions for the disease. Director Fan Qingyong introduced that percutaneous renal artery sympathetic nerve ablation (RDN) is a revolutionary and innovative treatment method to achieve blood pressure through minimally invasive catheter intervention. antihypertensive treatment options. It mainly uses radio frequency energy to ablate the sympathetic nerves distributed in the renal arteries, blocking the nerve signal conduction between the brain and the kidneys to a certain extent, thereby reducing the sympathetic nerve excitability in patients with hypertension, regulating the neuroendocrine system, and achieving a one-time Long-term stable antihypertensive effect of surgery. It is also the frontier field of clinical treatment of hypertension both at home and abroad. To a certain extent, it represents the future development direction of the discipline of hypertension in addition to the guidance of drug treatment and lifestyle intervention.
As a popular technique in the world, this operation is aimed at patients who cannot meet the standard of drug combination control, and has the characteristics of less trauma and quick recovery. , not only can reduce the patient’s medication, and even some patients do not need to take any more medication, on the one hand, it can reduce the blood pressure of patients with refractory and refractory hypertension; on the other hand, it can solve the problem of patients’ long-term oral medication. Director Fan Qingyong said that radiofrequency ablation using a mesh basket 6-electrode catheter was used in this operation, which was safe and effective, and took a short time. After minimally invasive interventional renal artery sympathetic nerve ablation, the patient’s blood pressure dropped to an ideal state during the operation.
The successful development of RDN surgery means that the treatment of hypertension in my country will change from “simple drug treatment” to “minimally invasive”. The new era of “interventional therapy” has brought new options and new hope for long-term and stable blood pressure control for hundreds of millions of hypertensive patients. At present, most of the hospitals that carry out RDN surgery in China are the top hospitals in the first-tier cities in the country. The team of Fan Qingyong, director of the Interventional Department of Heze Municipal Hospital, successfully carried out percutaneous renal artery sympathetic nerve ablation (RDN), which also marks the beginning of Heze Municipal Hospital It has entered the ranks of the top hospitals in the country with RDN technology, and has reached a new level in the diagnosis and treatment of essential hypertension.
